On a mini hiring spree, CRO Altasciences nabs ex-Charles River exec

Canadian pharmaceuticals
Canadian CRO Altasciences also added a new chief scientific officer just last month. (Shutterstock)

Just a month ago, Altasciences grabbed CRO veteran Beatrice Setnik, Ph.D., as its new chief scientific officer; now, it’s at it again.

The Canadian biopharma services company said it has hired Lynne LeSauteur, Ph.D., as its vice president of immunochemistry and immunology.

LeSauteur comes out of the Human Health Therapeutics Research Center at the National Research Council of Canada where she helped discover, biomanufacture and characterize new biologics alongside life sciences companies.

Webinar

How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDC

CROs are often at the forefront of adopting new technologies to make clinical trials more efficient. Hear how ICON, Lotus Clinical Research, and Bioforum are speeding database builds and automating reporting tasks for data management.

RELATED: Syneos Health exec jumps ship to Canadian CRO Altasciences

Before this, she served a stint at fellow CRO Charles River Labs, where she established its immunology department.

Marie-Hélène Raigneau, EVP of research services at Altasciences, said: “We are extremely pleased to welcome Lynne to the team at Altasciences. The breadth of her experience in both preclinical and clinical drug development, including her in-depth knowledge of immunotoxicology, immunogenicity, immunoassays, molecular biology, and biomarkers, will continue to enhance scientific guidance to our growing base of small- to mid-size clients.”

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

The FDA has cleared its first fully disposable duodenoscope, following years of reports of infections being transmitted between patients.

OR-focused AI provider Caresyntax has garnered $45.6 million in new funding and picked up a data analytics firm to broaden its footprint.